PURPOSE: To report a case of erosive conjunctivitis and punctal stenosis occurring secondarily in a patient who underwent administration of docetaxel. METHODS: Observational case report: a 58-year-old female with metastatic breast cancer developed erosive conjunctivitis and punctal stenosis after undergoing administration of systemic docetaxel. RESULTS: Resolution of the erosive conjunctivitis occurred after discontinuation of docetaxel. The punctal stenosis persisted. CONCLUSION: Patients receiving treatment with docetaxel require frequent monitoring to discover potentially irreversible ocular damage.
PURPOSE: To report a case of erosive conjunctivitis and punctal stenosis occurring secondarily in a patient who underwent administration of docetaxel. METHODS: Observational case report: a 58-year-old female with metastatic breast cancer developed erosive conjunctivitis and punctal stenosis after undergoing administration of systemic docetaxel. RESULTS: Resolution of the erosive conjunctivitis occurred after discontinuation of docetaxel. The punctal stenosis persisted. CONCLUSION:Patients receiving treatment with docetaxel require frequent monitoring to discover potentially irreversible ocular damage.